Step 5: Effective Drug Treatment of HIV
See also Antiretroviral Therapy, Adherence, and Initiating Treatment
Active Resources: 15
-
To help HIV care providers engage patients in care and transmission prevention, the Centers for Disease Control and Prevention (CDC) developed a new and comprehensive Prevention IS Care re
Type: Clinical Reference ToolsPublish Date: 6/30/2021 -
Training slides covering U.S. HHS treatment recommendations related to starting antiretroviral therapy (ART) in people with HIV infection.
Type: Training MaterialsPublish Date: 6/10/2021 -
The National HIV Curriculum (NHC) offers free online continuing education for novice-to-expert health professionals, students, and faculty.
Type: Online and Self-Paced LearningPublish Date: 9/14/2020 -
Slides from a 1-day course for primary care physicians and mid-level clinicians, which combines the latest research with current treatment guidelines for managing patients with HIV.
Type: Training MaterialsPublish Date: 7/31/2020 -
Training slides cover HHS recommendations for treatment of transgender people with HIV.
Type: Training MaterialsPublish Date: 1/31/2020 -
This training slide set covers aging-related concerns for people with HIV, including management of ART.
Type: Training MaterialsPublish Date: 1/31/2020 -
Excerpt from Introduction: The Department of Health and Human Services Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, a working group of t
Type: GuidelinesPublish Date: 12/24/2019Review Date: 12/30/2020 -
Excerpt from the Guidelines Introduction: "The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is a working group of
Type: GuidelinesPublish Date: 12/18/2019 -
Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment.
Type: Online and Self-Paced LearningPublish Date: 12/4/2019 -
In response to newly identified, community-based HIV epidemics, the AETC NCRC has pulled together the following AETC Program and U.S.
Type: Clinical Reference ToolsPublish Date: 6/10/2019 -
Guidelines for treating HIV-infected infants, children, and adolescents, including clinical monitoring, initiation of treatment, pediatric-specific drug information, and managing complications.
Type: GuidelinesPublish Date: 4/16/2019Review Date: 4/14/2020 -
This glossary of HIV/AIDS-related terms includes brief lay-oriented descriptions and illustrations. Materials are in the public domain and may be used freely.
Type: Clinical Reference ToolsPublish Date: 2/20/2019Review Date: 2/20/2019 -
Northeast/Caribbean (NECA) AETC offers online continuing education accredited videos and monographs.
Type: Online and Self-Paced LearningPublish Date: 2/5/2019Review Date: 6/11/2021 -
Webinar slides, recording, and resources. From Pacific AETC's HIV Learning Network session on linkage and retention in care for people with HIV.
Type: Online and Self-Paced LearningPublish Date: 2/28/2018 -
Resources to assist Ryan White and other HIV clinics to integrate buprenorphine programs within primary care settings. From the Integrating HIV Innovative Practices (IHIP) project.
Type: Training MaterialsPublish Date: 1/1/2013Review Date: 5/11/2021
Archive Resources: 13
-
This toolkit provides different assessment tools and guides to assist in addressing common health literacy issues in clinical care systems. The following are included in this CDC toolkit:
Type: Clinical Reference ToolsPublish Date: 2/2/2016 -
36 evidence-based recommendations are provided for interventions to optimize the HIV care environment; increase HIV testing and linkage to care, treatment coverage, retention in care, and vira
Type: GuidelinesPublish Date: 11/9/2015 -
Infographic provides recommendations to address gaps in the HIV care continuum related to HIV treatment and prevention for women and their partners.
Type: Clinical Reference ToolsPublish Date: 9/4/2015 -
Illustrates how improving patient self-management can help to reduce gaps along the HIV care continuum.
Type: Clinical Reference ToolsPublish Date: 7/1/2015Review Date: 5/18/2021 -
This toolkit was developed for use for members of the AETC Program and HIV health care professionals to serve as a resource guide on HIV and aging.
Type: Clinical Reference ToolsPublish Date: 4/29/2015 -
This infographic is a snapshot of how AETC NRC activities support and embrace the expertise of the broader AETC community and other national organizations.
Type: Clinical Reference ToolsPublish Date: 8/22/2014 -
The HIV/AIDS Bureau (HAB) of HRSA has developed a series of clinical performance indicators for Ryan White HIV/AIDS
Type: Clinical Reference ToolsPublish Date: 7/31/2014Review Date: 2/12/2018 -
This video describes HIV viral replication and where antiretroviral drugs work in the replication process.
Type: Online and Self-Paced LearningPublish Date: 7/17/2014 -
Patient education video discusses basic information about HIV infection, lab values, and the importance of adherence to ART regimen.
Type: Clinical Reference ToolsPublish Date: 7/7/2014Review Date: 5/8/2019 -
Pocket reference with interaction information and patient education recommendations. Order printed copies online from the NY/NJ AETC.
Type: Clinical Reference ToolsPublish Date: 2/1/2014 -
The 69 slides on Occupational Exposure to HIV, HCV, and HBV provide an overview of basic HIV information as well as fulfill the following objectives:
Type: Training MaterialsPublish Date: 1/15/2014 -
Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA,Infectious Diseases Society of America.
Type: GuidelinesPublish Date: 11/13/2013Review Date: 5/17/2019 -
The AETC Program national, regional, and local partners are a part of the HRSA-funded Ryan White HIV/AIDS Program.
Type: Clinical Reference ToolsPublish Date: 6/1/2013Review Date: 1/11/2017
Articles: 5
-
Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)
Treatment of tuberculosis (TB) in HIV-infected persons remains challenging, in part because of drug interactions between rifampin and some ARVs that may compromise antiretroviral therapy (ART). Three studies presented at CROI provide clinicians with additional guidance on how to manage certain...
-
Ibalizumab Approved for Persons with Multidrug Resistant HIV
Ibalizumab (TNX-355), an entry inhibitor, has been approved by the FDA for use in persons with an extensive ARV treatment history and multidrug resistant HIV who are on a failing ARV regimen. Ibalizumab (trade name: Trogarzo) is a monoclonal antibody that binds the CD4 receptor and blocks HIV...
-
CROI 2017: Failure of Dolutegravir Monotherapy
Leading up to this year, some researchers and clinicians had optimistically viewed dolutegravir an invincible ARV, a drug so mighty that it was unlikely to fail, and even more unlikely to be victim to emergent resistance mutations. Two presentations at CROI demonstrated the...
-
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy
Three studies presented at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) explored the pharmacokinetics of antiretrovirals administered during pregnancy. These studies support the use of standard-dose efavirenz, once-daily dolutegravir, and BID ritonavir-boosted...
-
Switching from TDF/FTC to TAF/FTC
Researchers at the 2016 Conference on Retroviruses and Opportunistic Infections presented results from a randomized double-blind, double-dummy switch study of TAF/FTC. Over 660 patients with virologic suppression on TDF/FTC-containing 3-drug regimens were either switched to TAF/FTC (200/10 mg...